Vitiligo. Vitiligo
Conditions
Interventions
Intervention 1: Treatment with NBUVB plus a topical ointment as the placebo. Intervention 2: Treatment with NBUVB plus local application of Piperine solition.
Placebo
Treatment - Drugs
Treatment with NBUVB plus a topical ointment as the placebo
Treatment with NBUVB plus local application of Piperine solition
Sponsors
Vice Chancellor of Research, Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: diagnosis of facial vitiligo Exclusion criteria: history of alopecia areatea; diabetes; Addison's disease; pernicious anemia; Graves disease; Hashimoto’s thyroiditis; systemic lupus erythematosus; history of treatment with NB-UVB in the past two weeks; history of applying topical medications in the past 2 weeks prior to the study
Exclusion criteria
Exclusion criteria:
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Patients satisfaction. Timepoint: After four months. Method of measurement: Objective score given by the patient on a scale of 0-10.;Side effects of the treatment. Timepoint: Every month. Method of measurement: History taking and physical examination. | — |
Primary
| Measure | Time frame |
|---|---|
| Repigmentation. Timepoint: Every month. Method of measurement: Objective evaluation by two blinded Dermatologists. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAnoosh Shafiee
Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences
Outcome results
None listed